Mumbai scientists found the switch behind vicious cancers — and how to flip it off

Skin and oral cancers that turn aggressive share a hidden control circuit: a chain reaction through three gene regulators — c-Jun, Sox2 and Hif1α — that drives growth, spread and resistance to therapy. Researchers at Mumbai's Tata Memorial Centre and ACTREC mapped the whole axis, then tested an innovative combination of existing drugs against it in lab and animal models. Tumour volumes shrank by up to 80%. Because the combo repurposes drugs doctors already know, the path from bench to bedside could be shorter than usual — fresh hope where current options fall short.